Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
PHARMAID-XNSE
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 43% |
| - | - | - | 14% |
| - | 11% | -15% | -44% |
| -23% | -23% | -22% | -22% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
PHARMAID-X
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,792 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 9,988.7 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,650 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,319.15 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,260.3 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,375 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,396.95 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,488.7 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,701.35 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,018.7 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 28.9 | ₹99 Cr | — | 0.63 | -0.75 | -₹12 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹4 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹2 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹30 L |
| ₹5 L | ₹10 L | ₹8 L | ₹22 L | ₹4 L | ₹7 L | ₹70,000 | ₹1 L | ₹90,000 | ₹12 L | -₹90 L | -₹26 L | ₹37 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 L |
| ₹4 Cr | ₹7 Cr | ₹6 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | -₹88 L | -₹26 L | ₹37 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹32 L |
| ₹5 Cr | ₹8 Cr | ₹8 Cr | ₹14 Cr | ₹13 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹11 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹9 Cr | ₹70 L | ₹54 L | ₹6 L | ₹31 L |
| -₹70 L | -₹24 L | -₹2 Cr | -₹5 Cr | -₹5 Cr | -₹4 Cr | -₹3 Cr | -₹2 Cr | -₹3 Cr | -₹5 Cr | -₹2 Cr | -₹1 Cr | -₹1 Cr | -₹9 Cr | -₹70 L | -₹54 L | -₹6 L | ₹1 L |
| ₹60 L | ₹65 L | ₹72 L | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹49 L | ₹34 L | ₹26 L | ₹77 L | ₹0 | ₹0 | ₹10,000 | ₹20,000 | ₹0 | ₹0 | ₹30,000 | ₹0 |
| ₹2 Cr | -₹1 Cr | -₹4 Cr | -₹4 Cr | -₹7 Cr | -₹5 Cr | -₹4 Cr | -₹3 Cr | -₹4 Cr | -₹7 Cr | -₹2 Cr | -₹1 Cr | -₹1 Cr | -₹9 Cr | -₹70 L | -₹54 L | -₹6 L | ₹90,000 |
| ₹2 Cr | -₹1 Cr | -₹3 Cr | -₹3 Cr | -₹5 Cr | -₹5 Cr | -₹3 Cr | -₹2 Cr | -₹3 Cr | -₹6 Cr | -₹2 Cr | -₹51 L | -₹1 Cr | -₹6 Cr | -₹71 L | -₹55 L | -₹14 L | ₹90,000 |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹35 Cr | ₹35 Cr | ₹35 Cr | ₹21 Cr | ₹10 Cr |
| ₹0 | ₹0 | ₹0 | ₹35 L | ₹0 |
| ₹12 Cr | ₹24 Cr | ₹37 Cr | ₹67 L | -₹2 Cr |
| ₹12 Cr | ₹24 Cr | ₹37 Cr | ₹67 L | -₹2 Cr |
| ₹48 Cr | ₹59 Cr | ₹72 Cr | ₹22 Cr | ₹9 Cr |
| -₹5 L | -₹4 Cr | -₹2 Cr | ₹0 | ₹0 |
| ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹0 | ₹0 |
| ₹8 Cr | ₹28 Cr | ₹0 | ₹0 | ₹0 |
| -₹12 Cr | -₹11 Cr | -₹7 Cr | -₹3 Cr | -₹36 L |
| ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹0 | ₹0 |
| ₹18 L | ₹78 L | ₹62 L | ₹0 | ₹0 |
| ₹3 Cr | ₹26 Cr | ₹3 Cr | -₹3 Cr | -₹36 L |
| — | — | — | — | — |
| ₹3 Cr | ₹16 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr |
| ₹12 Cr | ₹7 Cr | ₹5 Cr | ₹24 L | ₹13 L |
| ₹9 Cr | ₹5 Cr | ₹1 Cr | ₹0 | ₹0 |
| ₹5 L | ₹12 L | ₹8 L | ₹0 | ₹0 |
| ₹24 Cr | ₹29 Cr | ₹12 Cr | ₹2 Cr | ₹2 Cr |
| ₹75 Cr | ₹109 Cr | ₹85 Cr | ₹22 Cr | ₹11 Cr |
| ₹21 Cr | ₹35 Cr | ₹5 Cr | ₹0 | ₹0 |
| — | — | — | — | — |
| ₹59 Cr | ₹81 Cr | ₹66 Cr | ₹1 Cr | ₹51 L |
| ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹48 L |
| ₹54 Cr | ₹77 Cr | ₹63 Cr | ₹11 L | ₹3 L |
| ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹2 Cr | ₹45 L |
| ₹2 Cr | ₹6 Cr | ₹72 L | ₹1 Cr | ₹8 Cr |
| ₹2 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹64 Cr | ₹88 Cr | ₹71 Cr | ₹3 Cr | ₹8 Cr |
| — | — | — | — | — |
| ₹0 | ₹0 | ₹0 | ₹3 Cr | ₹0 |
| ₹41 L | ₹12 Cr | ₹4 Cr | ₹0 | ₹89 L |
| ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| ₹13 L | ₹82 L | ₹5 Cr | ₹13 Cr | ₹41 L |
| ₹3 Cr | ₹40 L | ₹16 L | ₹0 | ₹0 |
| ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹20 L | ₹3 L |
| ₹11 Cr | ₹21 Cr | ₹14 Cr | ₹18 Cr | ₹3 Cr |
| -₹13 Cr | -₹8 Cr | ₹2 Cr | ₹16 Cr | ₹23 L |
| ₹0 | ₹0 | ₹0 | ₹12 L | ₹0 |
| ₹75 Cr | ₹109 Cr | ₹85 Cr | ₹22 Cr | ₹11 Cr |
| ₹14 | ₹17 | ₹20 | ₹10 | ₹8 |
| ₹14 | ₹17 | ₹20 | ₹10 | ₹8 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| -₹16 Cr | -₹17 Cr | -₹16 Cr | -₹10 Cr | ₹14 L |
| ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹5 L | ₹84,120 |
| ₹10 Cr | -₹3 Cr | ₹1 Cr | ₹6 Cr | -₹41 L |
| -₹4 Cr | -₹15 Cr | -₹11 Cr | -₹4 Cr | -₹26 L |
| -₹4 Cr | -₹15 Cr | -₹11 Cr | -₹4 Cr | -₹26 L |
| ₹23 Cr | -₹12 Cr | -₹75 Cr | -₹5 Cr | ₹47 L |
| -₹20 Cr | ₹23 Cr | ₹78 Cr | ₹21 Cr | ₹0 |
| -₹69 L | -₹4 Cr | -₹8 Cr | ₹12 Cr | ₹21 L |
| ₹82 L | ₹5 Cr | ₹13 Cr | ₹41 L | ₹20 L |
| ₹13 L | ₹82 L | ₹5 Cr | ₹13 Cr | ₹41 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 4 out of 9 oscillators
RSI
47.37Neutral
STOCH %K
34.55Neutral
MACD Level(12,26)
-0.59Sell
Ultimate Oscillator
33.37Sell
Aroon Oscillator
-82.00Sell
BOP
1.00Buy
CCI
-74.91Neutral
Williams %R
-65.45Neutral
Momentum
-1.22Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 moving averages
EMA 9
28.52Buy
SMA 9
28.33Buy
EMA 21
29.07Sell
SMA 21
29.38Sell
EMA 50
29.97Sell
SMA 50
30.04Sell
EMA 200
35.01Sell
SMA 200
32.64Sell
WMA 20
28.82Buy
Pivot
Pivot
Classic
Resistance 5
35.00
Resistance 4
33.37
Resistance 3
31.74
Resistance 2
30.11
Resistance 1
29.09
Pivot
28.48
Support 1
27.46
Support 2
26.85
Support 3
25.22
Support 4
23.59
Support 5
21.96
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 32.99% | 32.99% | 32.99% | 32.99% | 32.99% | 5.14% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 67.01% | 67.01% | 67.01% | 67.01% | 67.01% | 94.86% |
Bulk & block deals
Name
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|
Insider trading & SAST
Client name
Prasanna Subramanya Bhat
Pratima Subrahmanya Bhat
Shankarappa Nagaraja Vinaya Babu
Shreedhara Shetty
Shankarappa Nagaraja Vinaya Babu (Revised)
Maliemadom Ramaswamy Iyer Mahadevan
Shankarappa Nagaraja Vinaya Babu
Mini Manikantan
Maliemadom Ramaswamy Iyer Mahadevan
Shreedhara Shetty
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08 Sep 2026 | KMP | Acquisition | 0.049028 | 0.06 | 0 | — | 17.29 K | 03 Sep 2026 | Gift | 22,700 | Insider Trading | — | Equity |
| 08 Sep 2026 | Immediate Relative | Disposal | 0.049028 | 0 | 0 | — | 17.29 K | 03 Sep 2026 | Gift | 963 | Insider Trading | — | Equity |
| 26 Sep 2025 | Other | Acquisition | 7.68 | 32.04 | 0 | — | 27.10 L | 25 Aug 2025 | Open Offer | 1,12,99,064 | SAST | 29(2) | — |
| 17 Sep 2025 | Other | Disposal | 2.51 | 14.53 | 0 | — | 8.85 L | 18 Aug 2025 | Open Offer | 51,25,621 | SAST | 29(2) | — |
| 15 Sep 2025 | Director | Acquisition | 0.283545 | 27.88 | 35 L | ₹35 | 1 L | 09 Sep 2025 | Off Market | 98,31,064 | Insider Trading | — | Equity Shares |
| 02 Sep 2025 | Designated Person | Disposal | 0.011342 | 0.35 | 2.46 L | ₹61.50 | 4 K | 29 Aug 2025 | Market Sale | 1,25,178 | Insider Trading | — | Equity Shares |
| 28 Aug 2025 | Director | Acquisition | 7.684659 | 27.59 | 16.84 Cr | ₹62.15 | 27.10 L | 25 Aug 2025 | Others | 97,31,064 | Insider Trading | — | Equity Shares |
| 20 Aug 2025 | Director | Disposal | 1.134179 | 0.28 | 2.49 Cr | ₹62.15 | 4 L | 14 Aug 2025 | Others | 1,00,000 | Insider Trading | — | Equity Shares |
| 20 Aug 2025 | Designated Person | Disposal | 0.425317 | 0.36 | 93.22 L | ₹62.15 | 1.50 L | 18 Aug 2025 | Others | 1,29,178 | Insider Trading | — | Equity Shares |
| 20 Aug 2025 | Director | Disposal | 2.509371 | 14.53 | 5.50 Cr | ₹62.15 | 8.85 L | 18 Aug 2025 | Others | 51,25,621 | Insider Trading | — | Equity Shares |
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Pharmaids Pharmaceuticals Ltd manufacture herbal cough syrups cold tablets pain reliever tablets active charcoal tablets joint pain ointments and much more. They are established in the year 1991 and are
Corporate Actions
Date
Type
Details
Company details
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Pharmaids Pharmaceuticals Share Price
28.90+0.82 (+2.92%)
-41.99% past 1 Year
News
Pharmaids Pharma reports Profit after tax of Rs -1.31 Crores, in the March 2026 quarter
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about compliance report
Equity
PHARMAID
Pharmaids Pharma reports Profit after tax of Rs -3.11 Crores, in the December 2025 quarter
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about voting results and scrutinizer report
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about appointment of independent director
Equity
PHARMAID
Pharmaids Pharma reports Profit after tax of Rs -1.65 Crores, in the September 2025 quarter
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about open offer
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about proceedings of AGM
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharma reports Profit after tax of Rs -4.36 Crores, in the June 2025 quarter
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about letter of offer
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about certificate
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about trading window closure
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharma reports Profit after tax of Rs -3.06 Crores, in the March 2025 quarter
Equity
PHARMAID
Pharmaids Pharma - Quaterly Results
Equity
PHARMAID
Pharmaids Pharmaceuticals informs about newspaper advertisement
Equity
PHARMAID